|
 |
OmnicefThis page contains recent news articles, when available, and an overview of Omnicef but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Omnicef (when available) Cefuroxime, a second-generation cephalosporin, is used to treat severe upper and lower respiratory tract infections, skin infections, otitis media, and surgical prophylaxis. For the treatment of the following infections (respiratory, skin, soft tissue, urinary tract infections, ear, nose, throat infectsion) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A ß-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staph. Also used to treat acute bacterial bronchitis in patients with COPD Mechanism Of Action: Cefuroxime, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cefuroxime interferes with an autolysin inhibitor. News Articles on Cefuroxime Medical Teams International Ships Medicines to West Bank - 05 Jan 2010 Medical Teams International sent $398754 worth of Omnicef antibiotics to the West Bank and Jerusalem this month. The shipment arrived safely for ... ReliefWeb (press release) A dyslexic walks into a doctor's office... - Jan 3, 2010 ..."Omeniself [Omnicef]." I was not likely to get that one either. 4. "Have you been here before?" "Returning paeshint [patient]." 5. "Date of birth? ... Psychology Today (blog) Teva gets FDA nod to market generic version of Abbott antibiotic - May 10, 2007 N) antibiotic Omnicef in both capsule and oral suspension forms. Omnicef capsules and Omnicef oral suspension had annual sales of about $325 million and ... Reuters India's Lupin gets US FDA approval for Cefdinir oral suspension drug - May 9, 2007 Abbott's Omnicef had a US sales of about 787 mln usd in 2006, according to IMS Health (nyse: RX - news - people ). Forbes US nod for Aurobindo's Cefdinir capsules - Jan 21, 2008 The drug falls under the anti-bacterial segment and is a generic equivalent of Abbott Laboratories, 'OMNICEF'. Earlier, the company also received the final ... सिफी - सिफी Aurobindo Pharma Gets Approval to Sell Generic Omnicef in US - Dec 18, 2007 By Suresh Seshadri. Dec. 19 (Bloomberg) -- Aurobindo Pharma Ltd., an Indian drugmaker, won regulatory approval to sell its copy of Abbott Laboratories's ... Bloomberg FDA OK's Generic Omnicef Suspension - Jun 6, 2006 Lupin said Tuesday it has been cleared to market a generic version of Abbott's Omnicef to treat bacterial infections. The company, headquartered in Mumbai, ... RedOrbit Patheon resumes Omnicef production after suspension - Dec 16, 2005 By Kirsty Barnes, 16-Dec-2005. Patheon has resumed normal production of Omnicef antibiotic powder after it voluntarily suspended production in September at ... OutSourcing-Pharma.com Medicis Says Aesthetics Look 'Hot' - Aug 8, 2007 It earned 28 cents a share when adjusting for the writedown of the long-lived asset value associated with Omnicef. (The company deemed these assets impaired ... TheStreet.com - TheStreet.com (subscription) Production problems hobble Patheon's bottom line - Mar 3, 2006 Patheon has encountered difficulties with the production of the antibiotic drug Omnicef at its Puerto Rico plant, leading to a warning letter from the US ... CBC.ca Lupin settles US patent row - Jun 20, 2007 In March this year, Abbott and Astellas Pharma sued Ranbaxy Laboratories [ Get Quote ], Teva and Sandoz for challenging the patent of Omnicef, which has ... Rediff Omnicef COD - Jul 15, 2007 ...safety and effectiveness of prescription drugs in the US is regulated by the Omnicef COD Union, the main body that regulates pharmaceuticals is Omnicef COD ... Sokwanele First-Time Generic Approvals: Omnicef, Lexapro, MetroLotion - May 26, 2005 May 26, 2005 — The US Food and Drug Administration (FDA) has approved first-time generic formulations of cefdinir 300-mg capsules for the treatment of ... Medscape Discount Omnicef Online - Jul 22, 2007 ...of Dollars. Discount Omnicef Online recoup this Discount Omnicef Online pharmaceutical companies may do a number of things:[2] * Carefully research the ... Sokwanele First-Time Generic Approvals: Proscar, Omnicef, Zaditor - Jun 20, 2005 June 20, 2005 — The US Food and Drug Administration (FDA) has approved first-time generic formulations of finasteride 5-mg tablets for the treatment of ... Medscape Cheap Omnicef COD - Mar 10, 2007 ...* 1 Medicine development and Cheap Omnicef COD testing * Cheap Omnicef COD Drug legislation and safety * 3 Scientific background * 4 Drugs used as medicines ... Sokwanele Medicis to Present At Morgan Stanley Pharmaceutical CEOs Unplugged … - Dec 29, 2006 OMNICEF(R) is a registered trademark of Abbott Laboratories, Inc. under a license from Fujisawa Pharmaceutical Co., Ltd. RESTYLANE(R) is a registered ... RedOrbit Pediatricians 2nd biggest drug ad target. - Nov 11, 2005 The products most heavily promoted to the children's specialists are Abbott's Omnicef, Pfizer's Zyrtec, Merck's Singulair, GlaxoSmithKline's Advair Diskus, ... Free with registration - UPI Health Business - AccessMyLibrary.com Omnicef from Canadian Pharmacy - Jun 4, 2007 ...of North Omnicef universities that Omnicef a degree in pharmacology or in related disciplines. * University of British Columbia - B.Sc in Pharmacology ... Sokwanele Omnicef Capsules.(NEW GENERICS)(Lupin Pharmaceuticals, Inc. drug … - Jul 10, 2006 An extended-spectrum semi-synthetic cephalosporin has been approved for Lupin Pharmaceuticals, Baltimore, (410) 576-2000. Cefdinir capsules, 300 mg, ... $4.95 - Drug Topics - ECNext Purchase Omnicef COD - Sep 7, 2007 ...to tell Purchase Omnicef COD is the study of Purchase Omnicef COD requires intimate knowledge of cell biology and biochemistry increasing, ... Sokwanele Omnicef Capsules. - Jul 10, 2006 Omnicef Capsules. An extended-spectrum semi-synthetic cephalosporin has been ... Cefdinir capsules, 300 mg, a generic equivalent of Abbott's Omnicef ... $9.94 - Drug Topics - Alacra Store Discount Omnicef COD - Jun 23, 2007 ...divided into two groups -- over-the-counter (OTC) medications, which are available without Discount Omnicef COD restrictions, and Prescription only ... Sokwanele Discount Omnicef COD - Sep 24, 2007 ...which are available without special restrictions, and Discount Omnicef COD only medicines (POM), which must be prescribed by a physician. ... Sokwanele Medicis to Present at Thomas Weisel Partners Growth Forum 7.0. - Jun 9, 2005 OMNICEF(R) is a registered trademark of Abbott Laboratories, Inc. under a license from Fujisawa Pharmaceutical Co., Ltd. RESTYLANE(R) is a registered ... $4.95 - Business Wire - ECNext ABT Gets a Hand From Its Non-Pharma Businesses - Apr 16, 2008 Offsetting that will be the loss of Omnicef sales as the company is not immune to generics. Honestly, the Lupron deal with Takeda is questionable as it will ... TheStreet.com - TheStreet.com (subscription) Losses mount at ailing Patheon - Sep 7, 2007 Patheon said the Carolina operations "have been performing consistently well," but their value has been impaired by generic versions of Omnicef, ... Toronto Star Drugmaker Patheon reports earnings hit - Dec 13, 2005 The company said subsidiary CEPH International Corp. had resumed normal production and shipments of Omnicef antibiotic oral powder after they had been ... Pay-Per-View - Daily Mercury - ProQuest Archiver Abbott Is Buoyed By Arthritis Drug, - Oct 19, 2006 But it also faces challenges, as major drugs such as antibiotic Omnicef and epilepsy-treatment Depakote stand to lose their patent protections, while safety ... Subscription - Wall Street Journal Online - Dow Jones & Company Drug Development; Lupin announces final US Food and Drug … - Jun 26, 2006 Lupin's Cefdinir Capsules are the AB-rated generic equivalent of Abbott Laboratories' Omnicef Capsules which had US sales of approximately $232 million for ... Pay-Per-View - Anti-Infectives Week - Factiva, from Dow Jones Teva gets generic Omnicef OK, starts shipping.(Teva Pharmaceutical … - May 21, 2007 The US Food and Drug Administration has granted approval for Israeli firm Teva Pharmaceutical Industries' Abbreviated New Drug Applications to market its ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Lupin Q4 net rises 173% to Rs137 crore - May 10, 2007 Lupin's cefdinir capsules and suspensions are copies of Abbott Laboratories Ltd's Omnicef, which had US sales of approximately $787 million in 2006, ... Livemint Production problems expected to hurt Patheon's third-quarter results. - Aug 30, 2006 One such issue occurred in 2004, when FDA cited Patheon for failing to control and correct out-of-specification fill weights of certain Omnicef powder ... $9.94 - Chemical Week - Alacra Store Contract drug maker Patheon aims to sell Puerto Rico plant - Dec 15, 2007 Outgoing chief executive Riccardo Trecroce also blamed losses in part on "significantly lower revenues" for the Abbott Laboratories antibiotic Omnicef due ... Toronto Star Abbott Reports 15.5 Percent Sales Growth in First Quarter. - Apr 18, 2007 ...(c) $224 (9.9) TriCor $223 8.7 --- --- $223 8.7 Ultane/Sevorane $48 (41.3) $126 0.7 (d) $174 (16.0) Omnicef $161 12.5 --- --- $161 12.5 Niaspan $142 n/a ... Free with registration - PR Newswire - AccessMyLibrary.com Launches boom as branded drugs lose patents. - Sep 24, 2007 Omnicef, which is an antibiotic branded drug made by Abbott, treats such bacterial ... Dava Pharmaceuticals distributes the authorized generic of Omnicef. ... $9.94 - Drug Store News - Alacra Store Abbott Reports 17.5 Percent Sales Increase in the Second Quarter - Jul 13, 2005 ...$219 22.9 Synthroid $113 (36.1) $14 (9.7) $127 (34.0) Omnicef* $85 62.8 ... which includes Biaxin (clarithromycin) and Omnicef, grew 10.0 percent. ... RedOrbit טבע: ×?ישור FDA לתרופה ×?× ×˜×™×‘×™×•×˜×™×ª - May 10, 2007 ...מדובר בגרסה ×’× ×¨×™×ª לתרופה Omnicef. הגרסה המקורית ×”×™×? של חברת Abott. המכירות ×”×©× ×ª×™×•×ª של התרופה ... ynet ידיעות ×?×—×¨×•× ×•×ª - ynet ידיעות ×?×—×¨×•× ×•×ª טבע: ×?ישור FDA ×ž×•×ª× ×” לתרופה לטיפול בסרטן - May 8, 2007 ...מספר השקות משמעותיות שעשויות להתרחש ×‘×¨×‘×¢×•× ×™×? הב×?×™×?: Lovenox, Omnicef, Lotrel,Aciphex ו-Celebrex. ... ynet ידיעות ×?×—×¨×•× ×•×ª - ynet ידיעות ×?×—×¨×•× ×•×ª Q4 2005 Patheon Inc. Earnings Conference Call - Part 2. - Dec 14, 2005 Or is this a matter of we've seen the impact of the Omnicef and the ... Clive talked about increasing volumes at Omnicef as we move through the first ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Event Brief of Q1 2005 Abbott Laboratories Earnings Conference Call -... - Apr 12, 2005 As ABT expected, both Biaxin and Omnicef experienced strong ... Omnicef in particular had another outstanding qtr. up nearly 90%. 3. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com המעו"×£ שובר שי×?×™×?: חת×? ב- 1028 × ×§' - Apr 4, 2007 ...חברת ×?בוט על הפרת ×¤×˜× ×˜ על תרופת ×”-omnicef, תרופה בעלת מכירות ×©× ×ª×™×•×ª של 640 מיליון ד' ×‘×©× ×”. ... NRG מעריב DRUG CAPSULE WHAT YOU SHOULD KNOW | Article from The … - Jan 30, 2006 OMNICEF (Cefdinir) What it does: Omnicef is an antibiotic that's used to treat bacterial infections such as strep thro... Pay-Per-View - Milwaukee Journal Sentinel - HighBeam Research Generic of Abbott Drug - Jun 2, 2006 The latest approval authorizes Lupin to make a generic of Omnicef in a ... Abbott also sells Omnicef, which pulled in nearly $500 million in sales last year ... Subscription - Wall Street Journal Online - Dow Jones & Company Abbott Reports 15.0 Percent Sales Increase in the Third Quarter - Oct 19, 2005 ...increased double digits in the third quarter, driven by strong contributions from major branded products including HUMIRA(R), Kaletra(R) and Omnicef(R). ... RedOrbit INDIA'S AUROBINDO PHARMA GETS US FDA NOD FOR CEFDINIR … - Jan 22, 2008 The drug is a generic equivalent of Abbott Laboratories Omnicef capsules. Omnicef capsules are used to treat patients, with mild to moderate infections ... Free with registration - AsiaPulse News - AccessMyLibrary.com Patheon loses $22M after restructuring - Jun 8, 2007 The Puerto Rico operations received a warning letter from US regulators in 2005 regarding production of Abbott's oral antibiotic Omnicef. ... Toronto Star Abbott Reports Record Sales, Earnings and Cash Flow in 2005 - Jan 25, 2006 ...growth of nearly 10 percent in the quarter was driven by continued strong performance of HUMIRA(R) and contributions from TriCor(R) and Omnicef(R). ... RedOrbit Event Brief of Q1 2007 Abbott Laboratories Earnings Conference Call -... - Apr 18, 2007 A more conservative financial planning assumption for Omnicef for 2007 and ... If sales of Omnicef exceed forecast, it would provide either additional ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Abbott Reports 15.5 Percent Sales Increase in the Fourth Quarter;... - Jan 18, 2005 TriCor(R), Kaletra(R), Omnicef(R) and Mobic(R). HUMIRA worldwide sales were $852 million for full-year 2004. Based on the performance of HUMIRA in 2004, ... $4.95 - PR Newswire - ECNext Patheon 'dissatisfied' as profits stagnate - Jun 5, 2006 The Mississauga-based firm now claims Omnicef is being manufactured on three production lines and volumes have returned to levels prior to receiving the ... OutSourcing-Pharma.com Abbott antibiotic faces generic threat - May 19, 2006 ...(Crain's) - The US Food and Drug Administration on Friday approved the first generic version of Abbott Laboratories' Omnicef, a fast-growing antibiotic that ... Crain's Chicago Business The Antibacterial Drug Market Analysis 2008-2013 - Mar 19, 2008 Abbott's Omnicef Currently Leads the. Cephalosporins Market. 4.2.1. Omnicef Will Lose Dominance in This Class to. Maxipime ... $4,356.00 - VISIONGAIN A - Alacra Store CEPH International. - Nov 1, 2005 27, cites the facility for failing to control and correct out-of-specification fill weights for certain versions of the "Omnicef OP" oral suspensions it ... $9.94 - Pharmaceutical Technology - Alacra Store Event Brief of Q3 2006 Abbott Laboratories Earnings Conference Call -... - Oct 1, 2006 Omnicef performing well. 1. Sales up more than 50%. 2. Omnicef one of the fastest growing antibiotics in US 2. As expected, Biaxin sales in 3Q06 declined, ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Abbott Reports Strong Third-Quarter Results, Announces $2.5 Billion … - Oct 18, 2006 The strong US performance was led by HUMIRA(R), Omnicef(R), Depakote(R), Kaletra(R) and TriCor(R), which all reported double-digit growth. ... $4.95 - PR Newswire - ECNext Abbott, partner sue to block regulatory OK of generic drug - Mar 31, 2007 Omnicef, used to treat ear, sinus, throat and skin infections, generated $637 million in sales last year for North Chicago-based Abbott. ... Pay-Per-View - Chicago Tribune - ProQuest Archiver Aurobindo, Dr. Reddy's, IFCI, Power Grid: India Stock Preview - Dec 18, 2007 Aurobindo Pharma Ltd. (ARBP IN): The Indian drugmaker won regulatory approval to sell its copy of Abbott Laboratories' antibiotic Omnicef in the US The ... Bloomberg Article: Manufacturers succeed in keeping product pipeline productive:... - Jul 24, 2006 Lupin, citing figures from IMS Health, says Omnicef generated 2005 sales of $137 million in the suspension form. Combined with a capsule version, ... Pay-Per-View - Chain Drug Review - HighBeam Research Lupin Pharmaceuticals Inc.(RX/GENERIC DRUGS--Profiles)(Company … - Sep 17, 2007 0.025% solution Cefdinir capsules, Lupin Ltd. Omnicef 300 mg capsules Escitalopram ... topical lotion, 0.75% Cefdinir for oral Lupin Pharmaceuticals Omnicef ... Pay-Per-View - Chain Drug Review - HighBeam Research Lupin Pharmaceuticals Inc.(RX/GENERIC DRUGS--Profiles) | Article from... - Sep 25, 2006 WASHINGTON -- Lupin Pharmaceuticals Inc. has received Food and Drug Administration ... of Abbott Laboratories' Omnicef. Lupin, citing figures from IMS ... Pay-Per-View - Chain Drug Review - HighBeam Research Firm swallows loss as sales trend down - Jun 9, 2007 The Puerto Rico operations received a warning letter from US regulators in 2005 regarding production of Abbott Laboratories' oral antibiotic Omnicef. ... Toronto Star Pharma majors face fresh cases in US - Apr 6, 2007 Omnicef had sales of US $637 million in the last year. Its patent expires in 2011. Malvinder Mohan Singh, managing director and CEO of Ranbaxy had told ... Rediff Patheon holders approve investment by JLL - Apr 19, 2007 The Puerto Rico site had run afoul of US regulators, who sent Patheon a warning letter in 2005 regarding its production of Abbott's oral antibiotic, Omnicef ... Toronto Star Antibiotic and Antiviral Drug Classes - Apr 14, 2008 Third generation includes cefpodoxime (Vantin), cefdinir (Omnicef) cefditoren (Sprectracef), cefixime (Suprax), and ceftibuten (Cedex). ... New York Times השקת ×”-Lotrel תוסיף ×œ×ž× ×™×ª טבע 9-11 ×¡× ×˜ בחצי ×©× ×” - May 21, 2007 ...במקרה של ×”-Omnicef דחה בית המשפט ×?ת צו ×”×ž× ×™×¢×” שביקשה ... השוק העריך שהתרופה Omnicef תושק ב 2009, ... Bizportal Sinusitis Medications - Sinusitis Health Information - NY Times Health - Jan 23, 2008 Third generation include cefpodoxime (Vantin), cefdinir (Omnicef) cefditoren (Sprectracef), cefixime (Suprax), and ceftibuten (Cedex). ... New York Times DRUG CAPSULE WHAT YOU SHOULD KNOW - Jan 30, 2006 What it does: Omnicef is an antibiotic that's used to treat bacterial infections such as strep throat, pneumonia, bronchitis, sinus infections, tonsillitis, ... $2.95 - Milwaukee Journal Sentinel - NewsBank Medicis Announces FDA Approval of AMMONUL for Urea Cycle Disorder. - Feb 18, 2005 OMNICEF(R) is a registered trademark of Abbott Laboratories, Inc. under a license from Fujisawa Pharmaceutical Co., Ltd. RESTYLANE(R) is a registered ... Free with registration - Business Wire - AccessMyLibrary.com Patheon's future up in the air as profits plummet - Sep 25, 2006 All these issues, in conjunction with the cost of corrective action the company had to take to address production issues with Abbott's antibiotic Omnicef ... In-PharmaTechnologist.com Chronic Obstructive Pulmonary Disease - Sep 24, 2008 Third generation: cefpodoxime (Vantin), cefdinir (Omnicef), cefditoren (Spectracef), cefixime (Suprax), and ceftibuten (Cedex). Ceftriaxone (Rocephin) is an ... New York Times Medicis to Present at Thomas Weisel Partners Healthcare Tailwinds... - Sep 6, 2005 OMNICEF(R) is a registered trademark of Abbott Laboratories, Inc. under a license from Fujisawa Pharmaceutical Co., Ltd. RESTYLANE(R) is a registered ... RedOrbit Emphysema Medications - Emphysema Health Information - NY Times … - Apr 8, 2008 Third generation: cefpodoxime (Vantin), cefdinir (Omnicef), cefditoren (Spectracef), cefixime (Suprax), and ceftibuten (Cedex). Ceftriaxone (Rocephin) is an ... New York Times News: ISRAEL-BUSINESS : Le géant du diagnostique US Abbott poursuit … - Apr 2, 2007 Omnicef a été développé par Astella Pharma, une firme japonaise qui est vendue ... Les ventes US d'Omnicef sont proches de 260 millions de dollars pour les ... IsraelValley Adding a server to a W-2000 LAN | 9 of 9 - May 7, 2005 Omnicef was right!!..., the problem were two mapped drives that I had in the work_group server. Once I delete those drives from the directory, ... TechRepublic Medicis and Ipsen Decide to Focus Partnership for Reloxin Exclusively... - Jul 12, 2006 In the USA, OMNICEF(R) is a registered trademark of Abbott Laboratories, Inc. under a license from Fujisawa Pharmaceutical Co., Ltd.; RESTYLANE(R) is a ... primezone.com Abbott Reports Strong Fourth-Quarter Results and Record Operating … - Jan 24, 2007 Kaletra $138 10.8 $159 7.7 (b) $297 9.1 Omnicef $259 36.9 --- --- $259 36.9 Biaxin (clarithromycin) $56 (40.0) $179 (4.7)(c) $235 (16.4) Ultane/Sevorane ... Free with registration - PR Newswire - AccessMyLibrary.com Oral cefdinir safe for penicillin-allergic patients.(Dermatology) - May 15, 2006 He reported that a literature review found virtually no cross-reactivity between cefdinir (Omnicef) and penicillin, despite concerns about the use of ... Free with registration - Internal Medicine News - AccessMyLibrary.com Ipsen to Grant Medicis Rights to Distribute and Promote Ipsen's... - Mar 13, 2006 OMNICEF(R) is a registered trademark of Abbott Laboratories, Inc. under a license from Fujisawa Pharmaceutical Co., Ltd. RESTYLANE(R) is a registered ... primezone.com Event Brief of Q3 2006 Abbott Laboratories Earnings Conference Call -... - Oct 18, 2006 Omnicef performing well. 1. Sales up more than 50%. 2. Omnicef one of the fastest growing antibiotics in US 2. As expected, Biaxin sales in 3Q06 declined, ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Medicis to Present at 24th Annual JPMorgan Healthcare Conference - Jan 6, 2006 OMNICEF(R) is a registered trademark of Abbott Laboratories, Inc. under a license from Fujisawa Pharmaceutical Co., Ltd. RESTYLANE(R) is a registered ... RedOrbit Medicis and BioMarin Reach Settlement. - Jan 12, 2005 OMNICEF(R) is a registered trademark of Abbott Laboratories, Inc. under a license from Fujisawa Pharmaceutical Co., Ltd. RESTYLANE(R) is a registered ... Free with registration - Business Wire - AccessMyLibrary.com Q1 2007 Patheon Inc. Earnings Conference Call - Part 2. - Mar 9, 2007 Stability issues and the problems you had with Omnicef. ... As far as the Omnicef issue, the FDA issues have been totally resolved, and I can safely say ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Puerto Rico's problems piling up - Nov 21, 2007 At its other Puerto Rican site in Carolina, Patheon ran into trouble with the FDA in 2005 regarding its production of Abbott's oral antibiotic, Omnicef ... In-PharmaTechnologist.com First-time generic approvals.(FDA Drug Approvals)(Brief article) - Jul 1, 2006 Cefdinir capsules, 300 mg (equiv to Omnicef capsules) LUPIN LIMITED Cefdinir for oral suspension, 125 mg/5 mL (equiv to Omnicef for oral suspension) LUPIN ... Free with registration - Formulary - AccessMyLibrary.com Manufacturers succeed in keeping product pipeline productive: the … - Jul 24, 2006 Lupin, citing figures from IMS Health, says Omnicef generated 2005 sales of $137 million in the suspension form. Combined with a capsule version, ... Free with registration - Chain Drug Review - AccessMyLibrary.com Oral cefdinir found safe for penicillin-allergic patients.(Infectious... - Mar 1, 2006 Dr. Del Rosso reported that a review of the literature found virtually no cross-reactivity between cefdinir (Omnicef) and penicillin, despite concerns over ... Free with registration - Pediatric News - AccessMyLibrary.com Medicis to Present at Merrill Lynch 17th Annual Global Pharmaceutical,... - Feb 3, 2006 OMNICEF(R) is a registered trademark of Abbott Laboratories, Inc. under a license from Fujisawa Pharmaceutical Co., Ltd. RESTYLANE(R) is a registered ... RedOrbit Manufacturing double whammy to cost Patheon millions - Aug 15, 2006 When manufacturing operations for Omnicef resumed after upgrading the equipment, volumes were squeezed by slower line speeds and lower yields, ... OutSourcing-Pharma.com Medicis Declares Cash Dividend - Mar 15, 2006 OMNICEF(R) is a registered trademark of Abbott Laboratories, Inc. under a license from Fujisawa Pharmaceutical Co., Ltd. RESTYLANE(R) is a registered ... primezone.com Medicis Announces FDA Approval of Broader Indication for VANOS - Mar 2, 2006 OMNICEF(R) is a registered trademark of Abbott Laboratories, Inc. under a license from Fujisawa Pharmaceutical Co., Ltd. RESTYLANE(R) is a registered ... primezone.com Medicis to Present at Wachovia Securities Equity Conference - Jun 14, 2006 OMNICEF(R) is a registered trademark of Abbott Laboratories, Inc. under a license from Fujisawa Pharmaceutical Co., Ltd. RESTYLANE(R) is a registered ... primezone.com Medicis Announces December 2005 Quarter-End Conference Call and … - Mar 10, 2006 OMNICEF(R) is a registered trademark of Abbott Laboratories, Inc. under a license from Fujisawa Pharmaceutical Co., Ltd. RESTYLANE(R) is a registered ... primezone.com Medicis Announces Second Quarter 2006 Conference Call and Webcast - Jul 31, 2006 OMNICEF(R) is a registered trademark of Abbott Laboratories, Inc. under a license from Fujisawa Pharmaceutical Co., Ltd. RESTYLANE(R) is a registered ... primezone.com Medicis Announces Third Quarter 2006 Conference Call and Webcast - Nov 6, 2006 OMNICEF(R) is a registered trademark of Abbott Laboratories, Inc. under a license from Fujisawa Pharmaceutical Co., Ltd. RESTYLANE(R) is a registered ... primezone.com Lupin Gets FDA Nod for Generic Antibiotic - May 30, 2006 According to a source quoted by the company, Omnicef Capsules had US sales of approximately $232 million last year. Cefdinir is an extended-spectrum ... RedOrbit Medicis Names Jason Hanson Executive Vice President and General … - Jul 12, 2006 OMNICEF(R) is a registered trademark of Abbott Laboratories, Inc. under a license from Fujisawa Pharmaceutical Co., Ltd. RESTYLANE(R) is a registered ... primezone.com Medicis to Present At Thomas Weisel Partners Healthcare Conference - Sep 5, 2006 OMNICEF(R) is a registered trademark of Abbott Laboratories, Inc. under a license from Fujisawa Pharmaceutical Co., Ltd. RESTYLANE(R) is a registered ... primezone.com Medicis to Present at Morgan Stanley 2006 Global Healthcare Unplugged... - Apr 28, 2006 OMNICEF(R) is a registered trademark of Abbott Laboratories, Inc. under a license from Fujisawa Pharmaceutical Co., Ltd. RESTYLANE(R) is a registered ... primezone.com Paving the path for Lupin - May 6, 2007 MUMBAI: Indian generic drugmaker Lupin may be able to launch Omnicef in the ... The ruling allows generic manufacturers to sell Omnicef in the US after the ... Daily News & Analysis (Euronext Paris) - Ipsen : Medicis and Ipsen decide to focus partnersh... - Dec 7, 2006 In the USA, OMNICEF® is a registered trademark of Abbott Laboratories, Inc. under a license from Fujisawa Pharmaceutical Co., Ltd.; RESTYLANE® is a ... euronext.com Medicis Announces First Quarter 2006 Conference Call and Webcast - May 4, 2006 OMNICEF(R) is a registered trademark of Abbott Laboratories, Inc. under a license from Fujisawa Pharmaceutical Co., Ltd. RESTYLANE(R) is a registered ... primezone.com Brand Names/Synonyms: Omnicef is also known by the following brand names and/or synonymsAncef; Biofuroksym; Ceclor; Ceclor Cd; Cedax; Cefditoren; Cefizox; Cefotan; Ceftin; Ceftizoxime Sodium; Cefurax; Cefuril; Cefuroxim; Cefuroxime; Cefuroxime Axetil; Cefuroxime Free Acid; Cefuroxime Sodium; Cefuroxime Sodium Salt; Cefuroxime [Usan:Ban:Inn]; Cefuroxime and Dextrose in Duplex Container; Cefuroximo [Inn-Spanish]; Cefuroximum [Inn-Latin]; Cefzil; Cephuroxime; Ceptaz; Duricef; Elobact; Fortaz; Keflex; Keftab; Kefurox; Kefurox in Plastic Container; Kerurox; Mandol; Maxipime; Mefoxin; Monocid; Omnicef; Oraxim; Rocephin; Sharox; Tazicef; Vantin; Velosef; Zinacef; Zinacef Danmark; Zinacef in Plastic Container; Zinat; Zinnat Drug Category: Omnicef is categorized under the following by the FDA: Anti-bacterial Agents; Cephalosporins; ATC:J01DC02 Dosage Forms: POWDER; POWDER FOR SOLUTION; TABLET Absorption: Well absorbed from the GI tract (bioavailability is 37-52%) Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 4-(carbamoyloxymethyl)-8-[2-(2-furyl)-2-methoxyimino-acetyl]amino-7-oxo-2-thia-6-azabicyclo[4.2.0]oct-4-ene-5-carboxylic acid |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |